CURE Media Group and Oncology Nursing News® announce
Mooney was recognized for her remarkable contributions in oncology care...
Stay updated with breaking news from Tyrone Brewer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mooney was recognized for her remarkable contributions in oncology care...
FDA approves Johnson & Johnson's Carvykti, a BCMA-targeted therapy for relapsed or refractory multiple myeloma patients, offering hope with increased manufacturing capacity and extended collaboration efforts.
The approval was based on data from the phase 3 CARTITUDE-4 study. The FDA has approved Carvykti for the treatment of adults with relapsed or refractory multiple myeloma after at least 1 prior lines of therapy.
The company's eighth annual Blue Jacket Fashion Show is dedicated to boosting the profile of prostate cancer and raising funds for research